Webcasts of the meeting

• Call to Order and Introduction of committee - Steven Dubinett, M.D., Chair
  Time: 00:00:01
• Conflict of Interest Statement - Gail Dapolito, Designated Federal Officer
  Time: 00:00:20
• Introductions
  Time: 00:03:40
• Apligraf (Oral), Organogenesis, Inc., BLA 125400
  Time: 00:09:14
• Introduction - Patrick Bilbo
  Time: 00:09:22
• Conditions and Treatments - David Cochran, D.D.S., M.S., Ph.D.
  Time: 00:26:20
• Clinical Efficacy and Safety - Damien Bates, M.D., Ph.D., FRACS (Plast.)
  Time: 00:43:02
• Benefit/Risk Summary - Michael McGuire, D.D.S.
  Time: 01:13:55
• Conclusions - Patrick Bilbo
  Time: 01:22:56
• Q&A
  Time: 01:24:03
• FDA Presentation
  Time: 02:30:57
• Product Quality - Mark H. Lee, Ph.D.
  Time: 02:31:20
• Overview of Periodontal Conditions and Treatments - Robert S. Betz, D.D.S., Captain (Ret), USPHS
  Time: 02:48:07
• Clinical Study Design and Safety and Efficacy - Agnes Lim, M.D.
  Time: 03:00:14
• Q&A
  Time: 03:24:07
• Open Public Hearing
  Time: 04:10:10
• Committee Discussion of Questions and Vote
  Time: 04:10:41
• Adjourn
  Time: 06:13:14